{
    "@context": {
        "schema": "https://schema.org/",
        "dct": "http://purl.org/dc/terms/",
        "hg": "https://hormuz.group/data/ns#"
    },
    "id": "hg:company:alborz-darou-pharmaceutical-company",
    "identifier": "hg:company:alborz-darou-pharmaceutical-company",
    "dataset_type": "entity_dataset",
    "entity_type": "company",
    "data_version": "2.0",
    "generated_by": "Hormuz Data Layer 0.2.1",
    "generated_at": "2026-07-04T02:51:16+00:00",
    "name": "Alborz Darou Pharmaceutical Company",
    "slug": "alborz-darou-pharmaceutical-company",
    "status": "publish",
    "url": "https://hormuz.group/companies/alborz-darou-pharmaceutical-company/",
    "json_url": "https://hormuz.group/wp-content/uploads/hormuz-data/cpt/company/alborz-darou-pharmaceutical-company.json",
    "rest_url": "https://hormuz.group/wp-json/hormuz-data/v1/cpt/company/alborz-darou-pharmaceutical-company",
    "summary": "",
    "machine_summary": "Alborz Darou Pharmaceutical Company Alborz Darou Pharmaceutical Company is a pharmaceutical manufacturer associated with Karaj and the Tehran-Alborz healthcare-industrial corridor. Its relevance comes from domestic medicine production, chronic-care demand, regulated healthcare pricing, raw-material dependency, and proximity to Iran’s largest consumer and institutional healthcare market. For Hormuz Group, the company helps map how pharmaceutical manufacturing capacity clusters around Tehran and Alborz while facing import dependence, technology gaps, and supply-continuity pressure. In the Hormuz investment graph, Alborz Darou Pharmaceutical Company connects domestic drug manufacturing, healthcare demand, pharmaceutical raw-material imports, regulated pricing, industrial capacity in Alborz, and medicine supply-chain resilience. It is useful for screening healthcare-sector demand, supplier mapping, import-substitution opportunities, and operational risk in pharma manufacturing. Commercial interpretation should verify current product mix, manufacturing licenses, raw-material sourcing, disclosure data, counterparty risk, export activity, and compliance constraints before being treated as actionable intelligence. Alborz Darou Pharmaceutical Company manufactures pharmaceutical products and dosage forms for healthcare, prescription medicine, chronic-disease treatment, and domestic medicine supply chains. Its product profile is linked to Iran’s regulated drug market, raw-material access, pharmaceutical quality requirements, healthcare consumption, and industrial capacity around the Tehran-Karaj pharmaceutical corridor. province: Alborz industry: Healthcare & Pharma, Manufacturing, Pharmaceuticals market: Consumer Demand, Healthcare, Materials, Supply Chains challenges: Compliance, Import Dependence, Supply Shortage, Technology Gap company_type: Manufacturer, Public Company city: Karaj",
    "published_at": "2026-06-28T18:12:53+00:00",
    "modified_at": "2026-06-28T18:12:53+00:00",
    "taxonomies": {
        "province": [
            {
                "id": 198,
                "name": "Alborz",
                "slug": "alborz",
                "url": "https://hormuz.group/provinces/alborz/"
            }
        ],
        "industry": [
            {
                "id": 21,
                "name": "Healthcare & Pharma",
                "slug": "healthcare-pharma",
                "url": "https://hormuz.group/industry/healthcare-pharma/"
            },
            {
                "id": 16,
                "name": "Manufacturing",
                "slug": "manufacturing",
                "url": "https://hormuz.group/industry/manufacturing/"
            },
            {
                "id": 121,
                "name": "Pharmaceuticals",
                "slug": "pharmaceuticals",
                "url": "https://hormuz.group/industry/healthcare-pharma/pharmaceuticals/"
            }
        ],
        "market": [
            {
                "id": 34,
                "name": "Consumer Demand",
                "slug": "consumer-demand",
                "url": "https://hormuz.group/market/consumer-demand/"
            },
            {
                "id": 69,
                "name": "Healthcare",
                "slug": "healthcare",
                "url": "https://hormuz.group/market/consumer-demand/healthcare/"
            },
            {
                "id": 73,
                "name": "Materials",
                "slug": "materials",
                "url": "https://hormuz.group/market/enterprise-demand/materials/"
            },
            {
                "id": 76,
                "name": "Supply Chains",
                "slug": "supply-chains",
                "url": "https://hormuz.group/market/enterprise-demand/supply-chains/"
            }
        ],
        "challenges": [
            {
                "id": 164,
                "name": "Compliance",
                "slug": "compliance",
                "url": "https://hormuz.group/challenges/regulatory-barriers/compliance/"
            },
            {
                "id": 176,
                "name": "Import Dependence",
                "slug": "import-dependence",
                "url": "https://hormuz.group/challenges/market-gaps/import-dependence/"
            },
            {
                "id": 177,
                "name": "Supply Shortage",
                "slug": "supply-shortage",
                "url": "https://hormuz.group/challenges/market-gaps/supply-shortage/"
            },
            {
                "id": 179,
                "name": "Technology Gap",
                "slug": "technology-gap",
                "url": "https://hormuz.group/challenges/market-gaps/technology-gap/"
            }
        ],
        "company_type": [
            {
                "id": 299,
                "name": "Manufacturer",
                "slug": "manufacturer",
                "url": "https://hormuz.group/company-type/manufacturer/"
            },
            {
                "id": 306,
                "name": "Public Company",
                "slug": "public-company",
                "url": "https://hormuz.group/company-type/public-company/"
            }
        ],
        "city": [
            {
                "id": 391,
                "name": "Karaj",
                "slug": "karaj",
                "url": "https://hormuz.group/cities/karaj/"
            }
        ]
    },
    "taxonomy_labels": {
        "province": "Alborz",
        "industry": "Healthcare & Pharma, Manufacturing, Pharmaceuticals",
        "market": "Consumer Demand, Healthcare, Materials, Supply Chains",
        "challenges": "Compliance, Import Dependence, Supply Shortage, Technology Gap",
        "company_type": "Manufacturer, Public Company",
        "city": "Karaj"
    },
    "fields_summary": {
        "legal_name": "Alborz Darou Pharmaceutical Company",
        "website": "http://www.alborzdarouco.com",
        "city": "Karaj, Alborz Province, Iran",
        "ticker_symbol": "دالبر",
        "listing_status": "listed_tse",
        "products_services": "Alborz Darou Pharmaceutical Company manufactures pharmaceutical products and dosage forms for healthcare, prescription medicine, chronic-disease treatment, and domestic medicine supply chains. Its product profile is linked to Iran’s regulated drug market, raw-material access, pharmaceutical quality requirements, healthcare consumption, and industrial capacity around the Tehran-Karaj pharmaceutical corridor.",
        "export_relevance": "low",
        "short_profile": "Alborz Darou Pharmaceutical Company is a pharmaceutical manufacturer associated with Karaj and the Tehran-Alborz healthcare-industrial corridor. Its relevance comes from domestic medicine production, chronic-care demand, regulated healthcare pricing, raw-material dependency, and proximity to Iran’s largest consumer and institutional healthcare market. For Hormuz Group, the company helps map how pharmaceutical manufacturing capacity clusters around Tehran and Alborz while facing import dependence, technology gaps, and supply-continuity pressure.",
        "investment_relevance": "In the Hormuz investment graph, Alborz Darou Pharmaceutical Company connects domestic drug manufacturing, healthcare demand, pharmaceutical raw-material imports, regulated pricing, industrial capacity in Alborz, and medicine supply-chain resilience. It is useful for screening healthcare-sector demand, supplier mapping, import-substitution opportunities, and operational risk in pharma manufacturing. Commercial interpretation should verify current product mix, manufacturing licenses, raw-material sourcing, disclosure data, counterparty risk, export activity, and compliance constraints before being treated as actionable intelligence."
    },
    "fields": {
        "rank_math_internal_links_processed": "1",
        "wp_statistics_words_count": "0",
        "legal_name": "Alborz Darou Pharmaceutical Company",
        "city": "Karaj, Alborz Province, Iran",
        "ticker_symbol": "دالبر",
        "export_relevance": "low",
        "verification_status": "basic",
        "data_confidence": "high",
        "listing_status": "listed_tse",
        "last_updated": "28/06/2026",
        "website": "http://www.alborzdarouco.com",
        "products_services": "Alborz Darou Pharmaceutical Company manufactures pharmaceutical products and dosage forms for healthcare, prescription medicine, chronic-disease treatment, and domestic medicine supply chains. Its product profile is linked to Iran’s regulated drug market, raw-material access, pharmaceutical quality requirements, healthcare consumption, and industrial capacity around the Tehran-Karaj pharmaceutical corridor.",
        "short_profile": "Alborz Darou Pharmaceutical Company is a pharmaceutical manufacturer associated with Karaj and the Tehran-Alborz healthcare-industrial corridor. Its relevance comes from domestic medicine production, chronic-care demand, regulated healthcare pricing, raw-material dependency, and proximity to Iran’s largest consumer and institutional healthcare market. For Hormuz Group, the company helps map how pharmaceutical manufacturing capacity clusters around Tehran and Alborz while facing import dependence, technology gaps, and supply-continuity pressure.",
        "investment_relevance": "In the Hormuz investment graph, Alborz Darou Pharmaceutical Company connects domestic drug manufacturing, healthcare demand, pharmaceutical raw-material imports, regulated pricing, industrial capacity in Alborz, and medicine supply-chain resilience. It is useful for screening healthcare-sector demand, supplier mapping, import-substitution opportunities, and operational risk in pharma manufacturing. Commercial interpretation should verify current product mix, manufacturing licenses, raw-material sourcing, disclosure data, counterparty risk, export activity, and compliance constraints before being treated as actionable intelligence.",
        "source_note": "Based on public company, market, sector, and disclosure-related information. Further verification is required before treating this profile as verified investment intelligence."
    },
    "field_profile": {
        "rank_math_internal_links_processed": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "wp_statistics_words_count": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "legal_name": {
            "type": "string",
            "present": true,
            "length": 35
        },
        "city": {
            "type": "string",
            "present": true,
            "length": 28
        },
        "ticker_symbol": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "export_relevance": {
            "type": "string",
            "present": true,
            "length": 3
        },
        "verification_status": {
            "type": "string",
            "present": true,
            "length": 5
        },
        "data_confidence": {
            "type": "string",
            "present": true,
            "length": 4
        },
        "listing_status": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "last_updated": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "website": {
            "type": "string",
            "present": true,
            "length": 28
        },
        "products_services": {
            "type": "string",
            "present": true,
            "length": 412
        },
        "short_profile": {
            "type": "string",
            "present": true,
            "length": 552
        },
        "investment_relevance": {
            "type": "string",
            "present": true,
            "length": 638
        },
        "source_note": {
            "type": "string",
            "present": true,
            "length": 175
        }
    },
    "sources": [
        {
            "type": "note",
            "value": "Based on public company, market, sector, and disclosure-related information. Further verification is required before treating this profile as verified investment intelligence."
        }
    ],
    "quality": {
        "required_fields": [
            "legal_name",
            "website",
            "city",
            "listing_status",
            "products_services",
            "export_relevance",
            "verification_status",
            "data_confidence",
            "short_profile",
            "investment_relevance",
            "source_note",
            "last_updated"
        ],
        "missing_required_fields": [],
        "missing_required_count": 0,
        "verification_status": "basic",
        "data_confidence": "high",
        "last_updated": "28/06/2026",
        "stale_over_180_days": false,
        "quality_score": 100
    },
    "verification": {
        "verification_status": "basic",
        "data_confidence": "high",
        "last_updated": "28/06/2026"
    }
}